{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:09:31Z","timestamp":1790622571943,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["RP-PG- 0616-20 008"],"award-info":[{"award-number":["RP-PG- 0616-20 008"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010527","name":"Public Health Scotland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024721","name":"Public Health Scotland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.psychres.2024.116028","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:15:06Z","timestamp":1718154906000},"page":"116028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: A national retrospective cohort study"],"prefix":"10.1016","volume":"339","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2023-9353","authenticated-orcid":false,"given":"Megan","family":"Glancy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-0173","authenticated-orcid":false,"given":"Norah","family":"Palmateer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-459X","authenticated-orcid":false,"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1962-951X","authenticated-orcid":false,"given":"Lee","family":"Barnsdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten MA","family":"Trayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1229-4838","authenticated-orcid":false,"given":"Saket","family":"Priyadarshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-6758","authenticated-orcid":false,"given":"Sharon","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6047-2400","authenticated-orcid":false,"given":"Andrew","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2024.116028_bib0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment\u2014A nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2024.116028_bib0026","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ije\/dyw060","article-title":"Data Resource Profile: the Scottish National Prescribing Information System (PIS)","volume":"45","author":"Alvarez-Madrazo","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.psychres.2024.116028_bib0032","article-title":"Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study","volume":"27","author":"Ashworth","year":"2023","journal-title":"Lancet Reg. Health"},{"key":"10.1016\/j.psychres.2024.116028_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-074668","article-title":"Association between benzodiazepine coprescription and mortality in people on opioid replacement therapy: a population-based cohort study","volume":"14","author":"Best","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2024.116028_bib0017","article-title":"Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: an analysis of overdose and all-cause mortality","volume":"123","author":"Bharat","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.psychres.2024.116028_bib0021","article-title":"Opioid-related deaths and their counterpart by occurrence-era, age-group and co-implicated drugs: Scotland versus England and Wales","author":"Bird","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2024.116028_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.31647","article-title":"Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States","volume":"3","author":"Bykov","year":"2020","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.psychres.2024.116028_bib0009","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2024.116028_bib0001","article-title":"Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review","volume":"0","author":"Degenhardt","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.psychres.2024.116028_bib0019","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1111\/add.16306","article-title":"Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: cohort study conducted using linked primary care, secondary care and mortality records","volume":"118","author":"Domzaridou","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.psychres.2024.116028_bib0022","article-title":"Gabapentinoids in Ireland 2010 to 2020: an observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and post mortem toxicology","author":"Durand","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2024.116028_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053487","article-title":"Trends in prescribing pattern of opioid and benzodiazepine substitutes among Medicare part D beneficiaries from 2013 to 2018: a retrospective study","volume":"11","author":"Esechie","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2024.116028_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and misuse of pregabalin and gabapentin: a systematic review update","volume":"81","author":"Evoy","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.psychres.2024.116028_bib0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acsptsci.2c00230","article-title":"Effects of gabapentinoids on heroin-induced ventilatory depression and reversal by naloxone","volume":"6","author":"Flynn","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.psychres.2024.116028_bib0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2016.08.627","article-title":"Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013*","volume":"167","author":"Gao","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2024.116028_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case\u2013control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.psychres.2024.116028_bib0028","series-title":"Scottish Index of Multiple Deprivation 2020","year":"2020"},{"key":"10.1016\/j.psychres.2024.116028_bib0042","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/dar.12448","article-title":"A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia","volume":"36","author":"Kingston","year":"2017","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.psychres.2024.116028_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.732345","article-title":"Opioids and gabapentinoids utilisation and their related-mortality trends in the United Kingdom primary care setting, 2010-2019: a cross-national, population-based comparison study","volume":"12","author":"Kurdi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2024.116028_bib0002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","article-title":"All-cause and cause-specific mortality among people using extramedical opioids: a systematic review and meta-analysis","volume":"77","author":"Larney","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2024.116028_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266142","article-title":"Relative effectiveness of medications for opioid-related disorders: a systematic review and network meta-analysis of randomized controlled trials","volume":"17","author":"Lim","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psychres.2024.116028_bib0034","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/add.13843","article-title":"Risk to heroin users of poly-drug use of pregabalin or gabapentin","volume":"112","author":"Lyndon","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.psychres.2024.116028_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002965","article-title":"Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records","volume":"16","author":"Macleod","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.psychres.2024.116028_bib0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2215-0366(19)30331-1","article-title":"Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England","volume":"6","author":"Marsden","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2024.116028_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103512","article-title":"From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic","volume":"100","author":"McAuley","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.psychres.2024.116028_bib0006","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1016\/S2468-2667(23)00082-8","article-title":"Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011\u201320: a national retrospective cohort study","volume":"8","author":"McAuley","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.psychres.2024.116028_bib0027","article-title":"Increasing drug-related mortality rates over the last decade in Scotland are not just due to an ageing cohort: a retrospective longitudinal cohort study","volume":"96","author":"McDonald","year":"2021","journal-title":"Int.l J. Drug Policy"},{"key":"10.1016\/j.psychres.2024.116028_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1129447","article-title":"Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health","volume":"14","author":"McHugh","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116028_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/jclp.23692","article-title":"Examining trauma, anxiety, and depression as predictors of dropout from residential treatment for substance use disorders","author":"Medenblik","year":"2024","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.psychres.2024.116028_bib0024","series-title":"Drug-Related Deaths in Scotland in 2022","year":"2023"},{"key":"10.1016\/j.psychres.2024.116028_bib0008","article-title":"Drug misuse and dependence: UK guidelines on clinical management","year":"2017","journal-title":"GOV.UK"},{"key":"10.1016\/j.psychres.2024.116028_bib0014","article-title":"Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: a nested case-control study","volume":"13","author":"Olopoenia","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.psychres.2024.116028_bib0025","doi-asserted-by":"crossref","DOI":"10.17061\/phrp2541541","article-title":"Unleashing the power of administrative health data: the Scottish model","author":"Pavis","year":"2015","journal-title":"Public Health Res. Pract."},{"key":"10.1016\/j.psychres.2024.116028_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109952","article-title":"Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States","volume":"249","author":"Powell","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2024.116028_bib0030","series-title":"Scottish Drug Misuse Database Report 2020\/21. 69","year":"2022"},{"key":"10.1016\/j.psychres.2024.116028_bib0029","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"10.1016\/j.psychres.2024.116028_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2024.116028_bib0036","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: an examination of reports to the european medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2024.116028_bib0043","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S2215-0366(19)30373-6","article-title":"Prescribing in primary care: art versus algorithm","volume":"6","author":"Shoptaw","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2024.116028_bib0004","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2024.116028_bib0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1176\/appi.ajp.2020.20071038","article-title":"The risk of overdose with concomitant use of Z-drugs and prescription opioids: a population-based cohort study","volume":"178","author":"Szmulewicz","year":"2021","journal-title":"AJP"},{"key":"10.1016\/j.psychres.2024.116028_bib0011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.psychres.2024.116028_bib0044","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/aje\/kwaa020","article-title":"Things don't always go as expected: the example of nondifferential misclassification of exposure\u2014bias and error","volume":"189","author":"Whitcomb","year":"2020","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.psychres.2024.116028_bib0013","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/add.15189","article-title":"Dual-trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study","volume":"116","author":"Zhou","year":"2021","journal-title":"Addiction"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124003135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124003135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:12:20Z","timestamp":1778670740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124003135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":44,"alternative-id":["S0165178124003135"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116028","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: A national retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116028"}}